Renalytix Plc Share Price
Stocks
RENX
GB00BYWL4Y04
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
London S.E.
16:35:27 19/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 5.350 GBX | 0.00% |
|
-0.93% | -9.32% |
| 10-28 | Renalytix Plc Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 10-28 | Earnings Flash (RENX.L) Renalytix plc Reports FY26 Revenue $3.0M | MT |
| Market Cap | 42.35M 38.61M 35.74M 32.36M 60.72M 3.95B 63.68M 431M 171M 2.14B 159M 156M 6.76B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 37.13M 33.85M 31.33M 28.37M 53.23M 3.46B 55.83M 378M 150M 1.88B 139M 136M 5.93B | EV / Sales 2026 * |
9.28x | EV / Sales 2027 * | 3.79x |
| Free-Float |
81.69% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| RENX | Delayed | |
| 2O9 | Delayed | ||
| 2O9 | Delayed | ||
| 2O9 | Real-time |
Last Transcript: Renalytix Plc
| 1 week | -0.93% | ||
| Current month | -1.83% | ||
| 1 month | -1.83% | ||
| 3 months | +35.44% | ||
| 6 months | +197.22% | ||
| Current year | -9.32% |
| 1 week | 5.15 | 5.6 | |
| 1 month | 5.15 | 6.1 | |
| Current year | 1.6 | 6.57 | |
| 1 year | 1.6 | 7 | |
| 3 years | 1.6 | 74.9 | |
| 5 years | 1.6 | 725.96 | |
| 10 years | 1.6 | 1,220 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McCullough
CEO | Chief Executive Officer | 58 | 14/03/2018 |
Joel Jung
DFI | Director of Finance/CFO | 68 | 27/05/2024 |
Howard Doran
PSD | President | 65 | 29/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
James McCullough
BRD | Director/Board Member | 58 | 14/03/2018 |
| Chairman | 74 | - | |
Fergus Fleming
BRD | Director/Board Member | 59 | 14/03/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 13/02/26 | Buy | Founder | 250 | 0.0001% | ||
| 13/02/26 | Buy | Chief Financial Officer | 500 | 0.0001% | ||
| 13/02/26 | Buy | Founder | 500 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -0.93% | -26.21% | -78.16% | 42.45M | ||
| -0.58% | -4.04% | +19.57% | +47.67% | 257B | ||
| -0.45% | -3.29% | +0.91% | +9.52% | 161B | ||
| -3.26% | -9.41% | -25.52% | +33.40% | 146B | ||
| -1.49% | -4.74% | -56.67% | -20.89% | 63.26B | ||
| -1.28% | -1.82% | +23.61% | +55.28% | 60.51B | ||
| -0.05% | +0.69% | +5.41% | -12.43% | 53.46B | ||
| -1.12% | -0.91% | +21.90% | +54.96% | 49.99B | ||
| -5.15% | -13.73% | -3.95% | +48.93% | 44.88B | ||
| -2.06% | -3.06% | +21.20% | +74.31% | 45.81B | ||
| Average | -1.26% | -3.15% | -1.97% | +21.26% | 88B | |
| Weighted average by Cap. | -0.95% | -3.95% | +1.66% | +32.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4M 3.65M 3.38M 3.06M 5.74M 373M 6.02M 40.73M 16.16M 202M 15M 14.69M 639M | 12.95M 11.81M 10.93M 9.9M 18.57M 1.21B 19.48M 132M 52.31M 655M 48.58M 47.57M 2.07B |
| Net income | -19.74M -18M -16.66M -15.08M -28.3M -1.84B -29.69M -201M -79.74M -998M -74.04M -72.51M -3.15B | -10.99M -10.02M -9.28M -8.4M -15.76M -1.03B -16.53M -112M -44.4M -556M -41.22M -40.37M -1.76B |
| Net Debt | -5.22M -4.76M -4.41M -3.99M -7.48M -487M -7.85M -53.16M -21.09M -264M -19.58M -19.17M -834M | 6.68M 6.09M 5.64M 5.1M 9.58M 623M 10.05M 68.02M 26.99M 338M 25.06M 24.54M 1.07B |
Employees
46
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/11/26 | GBX 5.350 | 0.00% | 589,176 |
| 18/11/26 | GBX 5.350 | 0.00% | 56,501 |
| 17/11/26 | GBX 5.350 | -0.93% | 646,273 |
| 16/11/26 | GBX 5.400 | 0.00% | 46,134 |
| 13/11/26 | GBX 5.400 | 0.00% | 193,359 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RENX Stock
Select your edition
All financial news and data tailored to specific country editions
















